|
 |
OluxThis page contains recent news articles, when available, and an overview of Olux but does not offer medical advice. You should contact your physician with regard to any health issues or concerns...."We are pleased to provide pharmacists and consumers with the authorized generic of Olux® - a trusted brand product," said Prasco Chief Executive Officer E. ... PR Newswire (press release) Perrigo Announces Dismissal Of Duac Patent Litigation - Update - Oct 19, 2009 The deal combined GSK's prescription dermatology products with Stiefel's portfolio, which included brands such as Duac, Olux and Soriatane. ... RTT News Perrigo gets FDA approval for generic Olux Foam - Mar 11, 2008 March 11 (Reuters) - Perrigo Co (PRGO.O) said regulators approved its generic version of Stiefel Laboratories' Olux Foam to treat moderate to severe ... Reuters Perrigo gets FDA nod for generic Olux Foam - Mar 11, 2008 March 11 (Reuters) - Drugmaker Perrigo Co (PRGO.O) said the US health regulators approved its generic version of Olux Foam for the treatment of moderate to ... Reuters … Laboratories Receives FDA Approval of Olux-E (Clobetasol Propionate... - Jan 23, 2007 CORAL GABLES, FL -- January 23, 2007 -- Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specializing in dermatology, ... DG News Perrigo Confirms Patent Challenge of Olux(R) Foam. - Oct 25, 2005 ALLEGAN, Mich., Oct. 25 /PRNewswire-FirstCall/ -- The Perrigo Company today announced that its Perrigo Israel Pharmaceuticals Ltd. (formerly Agis Industries ... Free with registration - PR Newswire - AccessMyLibrary.com Perrigo: FDA tentatively OKs scalp foam. - Sep 1, 2006 Final approval will not be granted until the expiration of a 30-month period, unless the patent on Olux Foam expires, or is judged to be invalid or not ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com FDA Approvals: Lialda and Olux-E - Jan 25, 2007 January 25, 2007 --- The US Food and Drug Administration (FDA) has approved mesalamine 1.2-g delayed-release tablets for the induction of remission in ... Medscape … Quarter Revenues Increase 19 Percent; OLUX, Soriatane and Evoclin ... - Aug 2, 2005 During the second quarter of 2005 prescriptions written for OLUX(R), ... This distributor relationship has been in place for Soriatane, OLUX and Luxiq(R) ... $4.95 - Business Wire - ECNext Q1 2006 Connetics Earnings Conference Call - Part 2. - May 3, 2006 Specific to OLUX on a product by product basis, clearly we take ... In this case, for OLUX, we believe the reserve rates were maybe $500 to $600000 higher ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Press Release: Perrigo Confirms Patent Challenge of Olux(R) Foam. -... - Oct 25, 2005 Perrigo Confirms Patent Challenge of Olux(R) Foam. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Dermatoses foam approved.(PRODUCTS)(Olux-E foam)(Brief article) - Apr 1, 2007 Olux-E (clobetasol propionate, 0.05%) foam, is indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive ... $4.95 - Internal Medicine News - ECNext Event Brief of Q4 2004 Connetics Earnings Conference Call - Part 1. - Jan 25, 2005 ...s existing product prescriptions for Luxiq, OLUX, and Soriatane were ... OLUX came in at $16.3m. 2. Luxiq $6.2m. 3. Soriatane contributed $17.8m. 4. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com DermTech and Stiefel Laboratories, Inc. Begin Feasibility Study to … - Jan 7, 2008 MimyX(R); Olux(TM) (clobetasol propionate, 0.05%) Foam; Olux-E(TM) (clobetasol propionate, 0.05%) Foam; Soriatane(R) (acitretin) CK CONVENIENCE KIT(TM); ... Free with registration - PR Newswire - AccessMyLibrary.com … Laboratories received FDA approval for Olux-E (clobetasol propionat... - Mar 1, 2007 Stiefel Laboratories received FDA approval for Olux-E (clobetasol propionate) foam, for the treatment of inflammatory and pruritic manifestations of ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Connetics Files Patent Infringement Lawsuit Against Agis, a Wholly- … - Oct 20, 2005 Connetics markets the drug product under the brand name OLUX(R) (clobetasol ... OLUX Foam is a super high-potency topical corticosteroid indicated for ... RedOrbit Dermatoses foam approved.(PRODUCTS)(Olux-E foam)(Brief article) | … - Apr 1, 2007 Dermatoses foam approved.(PRODUCTS)(Olux-E foam)(Brief article) ... find Internal Medicine News articles. Olux-E (clobetasol propionate, 0.05%) foam, ... Pay-Per-View - Internal Medicine News - HighBeam Research Olux-E.(FDA actions in brief)(treatment for corticosteroid-responsive... - Mar 1, 2007 Clobetasol foam, 0.05% (Olux-E, Stiefel) was approved for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses ... $4.95 - Formulary - ECNext Connetics Announces First Quarter Results with Product Sales up 79 … - Apr 26, 2005 First quarter 2005 sales of OLUX and Luxiq were $21.4 million, ... The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, ... $4.95 - Business Wire - ECNext Article: YAZ, Olux-E Foam, 0.05%.(New & Approved) - Pediatric News | ... - Mar 1, 2007 YAZ, Olux-E Foam, 0.05%.(New & Approved) ... find Pediatric News articles. YAZ (drospirenone and ethinyl estradiol tablets, Berlex Laboratories Inc.) The ... Pay-Per-View - Pediatric News - HighBeam Research Connetics commences Phase III clinical trial with Primolux for atopic... - Mar 24, 2005 Primolux will be delivered in the VersaFoam-EF emulsion formulation, a completely different delivery vehicle than Olux, which utilizes the hydro-ethanolic ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Article: YAZ, Olux, Humira, Cymbalta.(New & Approved) - May 1, 2007 YAZ (drospirenone and ethinyl estradiol tablets, Berlex Laboratories Inc.) The Food and Drug Administration approved a new indication for YAZ (drospirenone ... Pay-Per-View - Skin & Allergy News - HighBeam Research æ–°å?Žç¾Žé€šæ¶ˆæ?¯ï¼šStiefelLaboratories任命首任首å¸ç§‘å¦å®˜ - Apr 8, 2008 ...ç´ ç£·é…¸é…¯)Foam，1%ï¼›Luxiq®(å€?ä»–ç±³æ?¾æˆŠé…¸é…¯)Foam，0.12%ï¼›MimyX® Cream；也å?¯ 在Olux®/Olux-Eâ„¢ COMPLETE PACK ä¸èŽ·å¾—çš„Olux®(丙酸氯å€?ä»–ç´¢)Foam，0.05% å’ŒOlux-Eâ„¢( ... ä¸é‡‘在线 פריגו קיבלה ×?ישור לייצור ושיווק של תרופה לטיפול בצרבת; מכירות - Sep 26, 2006 ...החברה קיבלה בתחילת החודש מה-FDA ×?ישור ×ž×•×ª× ×” לשווק גירסה ×’× ×¨×™×ª לקצף Olux שפיתחה חברת Connetics ... ×”×?רץ Event Brief of Q1 2006 Connetics Earnings Conference Call - Part 1. - May 3, 2006 In March, CNCT hit all-time highs for OLUX. 1. The prescription trends for OLUX and Soriatane are below forecast levels. 2. Given this run rate, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Stiefel Laboratories nomme son premier directeur scientifique - Apr 8, 2008 0,05 % et la mousse Olux-E(TM) (clobetasol propionate), 0,05 % aussi disponible dans le KIT COMPLET Olux(R) / Olux-E(TM) ; les capsules Soriatane(R) ... Caducée.net Finance; Dermatology company reports Q4 net income of $6.4M; product ... - Feb 22, 2005 Combined OLUX and Luxiq revenues increased 19% compared with the fourth quarter of 2003. Selling, general, and administrative (SG&A) expenses increased to ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Ð’ СШÐ? в марте начнетÑ?Ñ? выпуÑ?к препарата Olux-Eâ„¢ длÑ? лечениÑ? пÑ?ор - Jan 25, 2007 FDA зарегиÑ?трировало препарат Olux-Eâ„¢ (Сlobetasol propionate) длÑ? лечениÑ? пÑ?ориаза и Ñ?кземы у пациентов в возраÑ?те 12 лет и Ñ?тарше. ВыпуÑ?к его ожидаетÑ?Ñ? уже ... ФармацевтичеÑ?кий веÑ?тник Finance; Dermatology company reports Q4 net income of $6.4M; product ... - Feb 25, 2005 Combined OLUX and Luxiq revenues increased 19% compared with the fourth quarter of 2003. Selling, general, and administrative (SG&A) expenses increased to ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Stiefel Laboratories Announces Expiration of Hart-Scott-Rodino... - Jul 29, 2008 Olux(R) (clobetasol propionate) Foam, 0.05% and Olux-E(R) (clobetasol propionate) Foam, 0.05% also available in the Olux(R) / Olux-E(R) COMPLETE PACK; ... Lifescience-online Ventiv Announces New Partnership with Connetics Corporation; … - Apr 14, 2005 OLUX absorbs quickly after it is applied to the skin, ... The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, ... $4.95 - PR Newswire - ECNext Press Release: Stiefel Laboratories, Inc. Successfully Completes... - Aug 5, 2008 Olux(R) (clobetasol propionate) Foam, 0.05% and Olux-E(R) (clobetasol propionate) Foam, 0.05% also available in the Olux(R) / Olux-E(R) COMPLETE PACK; ... Pay-Per-View - PR Newswire - HighBeam Research Connetics Launches Verdeso Foam for the Treatment of Mild-to-Moderate... - Nov 8, 2006 The Company's commercial products are OLUX (clobetasol propionate) Foam, 0.05%; LuxÃq (betamethasone valerate) Foam, 0.12%; Soriatane® (acitretin) capsules; ... RedOrbit Press Release: Stiefel Laboratories, Inc. Commences Tender Offer to … - Jul 8, 2008 Olux(R) (clobetasol propionate) Foam, 0.05% and Olux-E(R) (clobetasol propionate) Foam, 0.05% also available in the Olux(R) / Olux-E(R) COMPLETE PACK; ... Pay-Per-View - PR Newswire - HighBeam Research Trapped in one's own skin: though no cure is available for psoriasis,... - Sep 17, 2007 Two newly approved foam formulations of clobetasol propionate (Olux and ... Regardless of the Olux formulation selected, treatment should be limited to two ... Free with registration - Drug Topics - AccessMyLibrary.com FDA Approves Connetics' Verdeso Foam for the Treatment of Mild-to- … - Sep 19, 2006 In addition to Verdeso, Connetics' VersaFoam-based products are OLUX for scalp ... The Company's commercial products are OLUX (clobetasol propionate) Foam, ... Free with registration - Business Wire - AccessMyLibrary.com Press Release: Stiefel Laboratories, Inc. Announces Expiration of... - Jul 29, 2008 Olux(R) (clobetasol propionate) Foam, 0.05% and Olux-E(R) (clobetasol propionate) Foam, 0.05% also available in the Olux(R) / Olux-E(R) COMPLETE PACK; ... Pay-Per-View - PR Newswire - HighBeam Research Event Brief of Q4 2005 Connetics Earnings Conference Call - Final. - Jan 31, 2006 4Q05 prescriptions for Olux and Luxiq slightly below expectations. 4. ... Olux had a 4% growth rate YoverY. 2. Luxiq had a 3% YoverY growth rate. 3. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com ë°”ë¥¸ì–¸ë¡ ë¹ ë¥¸ë‰´ìŠ¤ ì?¸í„°ë„· 연합뉴스 - May 7, 2008 MimyX(R)í?¬ë¦¼; Olux(R) (clobetasol propionate) Foam, 0.05% 와 Olux(R) / Olux-E(TM) COMPLETEPACKì—?ë?„ ì?´ìš© 가능한 Olux-E(TM) (clobetasol propionate) Foam, ... 연합뉴스 Connetics Presents 11 Scientific Posters at American Academy of … - Feb 17, 2005 Psoriasis also will be a focused topic with posters presented on OLUX(R), ... OLUX/Dovonex 6 Month Follow up Study 10. Evoclin and Benzoyl Peroxide Skin ... $4.95 - Business Wire - ECNext Company Profile Report - Dec 16, 2006 LuxÃq Foam competes in the mid-potency topical steroid market while OLUX Foam competes ... Olux (Clobetasol Propionate); Luxiq (Betamethasone Valerate) Foam ... $50.00 - Revere Reports - Revere Stiefel Laboratories 任命首任首å¸ç§‘å¸å®˜ - Apr 8, 2008 ...å€?ä»–ç±³æ?¾æˆŠé…¸é…¯ï¼‰Foam，0.12%ï¹”MimyX(R) Cream﹔也å?¯åœ¨Olux(R)/Olux-E(TM) COMPLETE PACK ä¸ç?²å¾—çš„Olux(R)（丙酸氯å€?他索）Foam，0.05% å’ŒOlux-E(TM)（丙酸氯å€?ä»– ... 財è?¯ç¶² Article: FDA tentatively approves Perrigo psoriasis treatment: Sales... - Sep 3, 2006 The ethical version of the drug, Olux is marketed by Connectics Corporation (Nasdaq: CNCT) and had sales totaling $78 million in the twelve months ending ... Pay-Per-View - Globes - HighBeam Research Stiefel Laboratories 收購ABR Invent å’ŒABR Development - May 7, 2008 ...å€?ä»–ç±³æ?¾æˆŠé…¸é…¯ï¼‰Foam，0.12%ï¹”MimyX(R) Cream﹔也å?¯åœ¨Olux(R)/Olux-E(TM) COMPLETE PACK ä¸ç?²å¾—çš„Olux(R)（丙酸氯å€?他索）Foam，0.05% å’ŒOlux-E(TM)（丙酸氯å€?ä»– ... 財è?¯ç¶² Drug/Medical Device - Dec 16, 2006 LuxÃq Foam competes in the mid-potency topical steroid market while OLUX Foam competes ... Olux (Clobetasol Propionate), Short-Term Topical Treatment Of The ... $70.00 - Revere Reports - Revere FDA ruling, patient noncompliance hinder atopic dermatitis treatment.(... - Mar 1, 2007 ..."Olux-E is an emollient version of Olux and is designed for areas that need moisturizing as well as treatment" says Joel Schlessinger, MD, president of the ... $4.95 - Dermatology Times - ECNext Competitors by Product Report - Dec 16, 2006 LuxÃq Foam competes in the mid-potency topical steroid market while OLUX Foam competes ... Olux (Clobetasol Propionate); Luxiq (Betamethasone Valerate) Foam ... $75.00 - Revere Reports - Revere Topicals add new twists for pediatric dermatoses treatment.(Special … - Apr 1, 2007 Treatment with Olux-E should be limited to two consecutive weeks and no more than 50 g, or 21 capfuls a week, and Verdeso treatment is recommended for ... $4.95 - Dermatology Times - ECNext Stiefel acquisition marries technology, marketing: foam vehicle... - Mar 1, 2007 Another product using the emollient vehicle, Olux-E, approved for ... Therefore, he says, "Having Olux-E in an emollient foam is a big advantage." ... $4.95 - Dermatology Times - ECNext COMUNICADO: Stiefel Laboratories elige a su primer director cientÃfico - Apr 8, 2008 MimyX(R) Crema; Olux(R) (propionato de clobetasol) Espuma, 0,05% y Olux-E(TM) ... 0,05% también disponible en el PAQUETE COMPLETO Olux(R) / Olux-E(TM); ... elEconomista.es Press Release: Topical Therapies Show Promise for the Treatment of … - Mar 2, 2006 Article: Stiefel Laboratories Receives FDA Approval of Olux-E (Clobetasol ... ... Olux-E ... only my patients with psoriasis but also those with eczema," ... Pay-Per-View - PR Newswire - HighBeam Research Q3 2005 Connetics Earnings Conference Call - Part 2. - Nov 1, 2005 Could you describe the magnitude of the price increases that you guys took in the third quarter on the products, OLUX, Luxiq, Soriatane [inaudible]? ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Connetics Reports Second Quarter Financial Results. - Aug 14, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) ... $4.95 - Business Wire - ECNext Stiefel Laboratories Will Enter Into Private Equity Minority Investmen... - Aug 9, 2007 Luxiq(R) (betamethasone valerate) Foam, 0.12%; MimyX(R); Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; ... Free with registration - PR Newswire - AccessMyLibrary.com New Rogaine(R) Foam Features Connetics' Proprietary VersaFoam(R) … - Sep 5, 2006 Connetics' VersaFoam-based products are OLUX(R) for scalp dermatoses and ... The Company's marketed products are OLUX (clobetasol propionate) Foam, 0.05%; ... Free with registration - Business Wire - AccessMyLibrary.com DUSA Announces Stiefel's Receipt of Pricing Approval of Levulan PDT... - Mar 6, 2008 1%; Luxiq ® (betamethasone valerate) Foam, 0.12%; MimyX ® ; Olux TM (clobetasol propionate) Foam, 0.05%; Olux-E TM (clobetasol propionate) Foam, 0.05%; ... marketwire.com DUSA Expands Global Sales With Launch of Levulan ® Kerastick ® in … - Oct 1, 2007 1%; Luxiq ® (betamethasone valerate) Foam, 0.12%; MimyX ® ; Olux TM (clobetasol propionate) Foam, 0.05%; Olux-E TM (clobetasol propionate) Foam, 0.05%; ... marketwire.com Article: Low-sugar, organic and whole-wheat label claims selling best... - Jun 1, 2005 Administration (FDA) has issued an approvable letter to Connetics for its supplemental new drug application (sNDA) to expand label claims for Olux to ... Pay-Per-View - Packaging Digest - HighBeam Research Combination topical therapy for the treatment of psoriasis. - Mar 1, 2006 The development of clobetasol propionate foam 0.05% (clobetasol propionate foam/Olux) offers a convenient topical corticosteroid that can be used ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com FDA Approves Extina(R) for the Treatment of Seborrheic Dermatitis - Jul 17, 2007 0.12%; MimyX(R) Cream; Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) capsules; ... RedOrbit Stiefel Laboratories, Inc. Enters into Strategic Collaboration with... - Nov 6, 2007 Luxiq(R) (betamethasone valerate) Foam, 0.12%; MimyX(R); Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; ... Free with registration - PR Newswire - AccessMyLibrary.com Connetics Reports Positive Results From Desilux Phase III Trial; NDA ... - Aug 15, 2005 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... $4.95 - Business Wire - ECNext Stiefel Laboratories, Inc. Kuasai ABR Invent dan ABR Development - May 7, 2008 Busa, 0.12 persen; MimyX(R) Krim; Olux(R) (klobetasol propionate) Busa, 0.05 persen dan Olux-E(TM) KEMASAN LENGKAP; Soriatane(R) (acitretin) Kapsul tersedia ... ANTARA Stiefel Laboratories Angkat Kepala Ilmiah Utama - Apr 8, 2008 Busa, 0.12 persen; MimyX(R) Krim; Olux(R) (klobetasol propionate) Busa, 0.05 persen dan Olux-E(TM) KEMASAN LENGKAP; Soriatane(R) (acitretin) Kapsul tersedia ... ANTARA Atopic Dermatitis; Phase III clinical trial with Primolux for atopic... - Apr 11, 2005 Primolux will be delivered in the VersaFoam-EF emulsion formulation, a completely different delivery vehicle than OLUX, which utilizes the hydroethanolic ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Stiefel Laboratories Moves to Solidify, Enhance Its Leadership... - Apr 23, 2007 0.12%; MimyX(TM) Cream; Olux(R) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) capsules; ... $4.95 - PR Newswire - ECNext Atopic Dermatitis; Phase III clinical trial with Primolux for atopic... - Apr 15, 2005 Primolux will be delivered in the VersaFoam-EF emulsion formulation, a completely different delivery vehicle than OLUX, which utilizes the hydroethanolic ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Phytohealth Corp acquires United Biotech Corp (pending) - Deal … - Jul 1, 2005 PIERRE FABRE MEDICAMENT-COMPANY INSIGHT · PIERRE FABRE MEDICAMENT-COMPANY INSIGHT, Life Science Analytics, Aug 13 2008, $1920.00 …for Olux was in the United ... Pay-Per-View - deals - Alacra Store Centron: organic growth continued to fuel revenue for this relatively... - Jul 1, 2008 ...with additional business coming in from Duramed; Solvay (Parkinson's product); and Stiefel Laboratories (Soriatane, Verdeso, Olux, Olux-E, and Luxiq). ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Press Release: Starpharma Signs Collaborative Research Agreement … - Dec 3, 2007 R); Olux(TM) (clobetasol ... capsules; Verdeso(TM) (desonide ... around the world. ... Topical Gel, MimyX(TM) Cream, Olux(R ... R), Evoclin(TM), Verdeso(TM) ... Pay-Per-View - PR Newswire - HighBeam Research Foam form of steroid just approved. - Feb 5, 2007 Olux-E Foam 0.05%, from Steifel Laboratories, was recently approved by the FDA and will be ... Olux-E will be available in both 50- and 100-gm canisters. ... $9.94 - Drug Topics - Alacra Store Business & Finance; Dermatology company reports fourth-quarter … - Mar 7, 2006 Fourth-quarter 2005 product revenues included OLUX sales of $14.7 million, Soriatane sales of $13.6 million, Evoclin sales of $6.9 million, and Luxiq sales ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Connetics Reports Highlights of 2005 Analyst and Investor Day;... - Apr 14, 2005 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... $4.95 - Business Wire - ECNext Drug/Medical Device Report Stiefel Laboratories, Inc. - Feb 23, 2008 Connectics Olux E (Clobetasol. Propionat)/Formerly Primolux ... Connectics Olux (Clobetasol. Propionate). Short-Term Topical Treatment ... $70.00 - Revere Reports - Revere Daiichi Sankyo.(Update) | Article from Medical Marketing & Media | … - Dec 1, 2008 Olux, Olux-E, Luxiq, Soritane; Daiichi-Sankyo: CS-8663; Eisai, Inc.: Inavra ... Medical Marketing & Media. Article: Cardiovascular.(PIPELINE 2009) ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Article: Two ointments show similar efficacy for vitiligo.(Pediatric ... - Sep 1, 2008 Journal of Drugs in Dermatology; March 1, 2004 ; 700+ words ... ... recommend intermittent therapy with clobetasol propionate 0.05% foam (Olux Foam[R ... Pay-Per-View - Skin & Allergy News - HighBeam Research Press Release: Perrigo Company Announces Launch of Clobetasol … - Mar 20, 2008 Sales for the brand, Olux(R) Foam, 0.05%, were approximately $85 million according to Wolters Kluwer data for the 12 months ending January 2008. ... Pay-Per-View - PR Newswire - HighBeam Research Article: Correction.(Correction notice) - Skin & Allergy News |... - Jun 1, 2006 Article: OLUX(R) Foam Improves Disease Severity, Satisfaction and Quality . ... Article: Results From Trial of OLUX(R) the Treatment of Mild-to-Moderate . ... Pay-Per-View - Skin & Allergy News - HighBeam Research Stiefel Laboratories, Inc. Enters into Strategic Collaboration with... - Nov 6, 2007 Luxiq(R) (betamethasone valerate) Foam, 0.12%; MimyX(R); Olux(TM) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; ... $4.95 - PR Newswire - ECNext Platform Computing Inc acquires Scali Inc-Scali Manage from Scali Inc... - Oct 29, 2007 M Olux Foam (clobetasol propionate) Scaly Scalp M Abgenix Inc; Amgen Inc. Pfizer Inc. Olux Foam (clobetasol propionate) Psoriasis…LSA. ... Pay-Per-View - deals - Alacra Store [U] Connetics Corp. v. Agis Industries Ltd., No. 05-5038 (DNJ... - Apr 14, 2008 ...from an Abbreviated New Drug Application ("ANDA") filed by Agis in anticipation of marketing a generic version of Connetics' OLUX(r) brand drug product. ... $2.95 - U.S. District Court, District of New... - VersusLaw Ð?овоÑ?ти биофармы - Jan 31, 2007 FDA зарегиÑ?трировало препарат Olux-E (Сlobetasol propionate) длÑ? лечениÑ? пÑ?ориаза и ... Olux-E разработан американÑ?кой компанией Stiefel Laboratories, ... КоммерчеÑ?каÑ? биотехнологиÑ? Article: Clinical trial shows improvement in pressure ulcer healing.(p... - Aug 1, 2006 Article: OLUX[R], treats mild-to-moderate nonscalp psoriasis. (New ... Dermatology Nursing; August 1, 2002 ; 549 words ... ... focused exclusively on the ... Pay-Per-View - Dermatology Nursing - HighBeam Research Medicis launches treatment for plaque-type psoriasis.(New Products)( … - Feb 1, 2006 Article: OLUX[R], treats mild-to-moderate nonscalp psoriasis. (New ... Dermatology Nursing; August 1, 2002 ; 549 words ... ... 2002 at the 26th Annual ... Pay-Per-View - Dermatology Nursing - HighBeam Research Perrigo enjoys record third quarter, but gets pounded by investors - May 6, 2008 A generic form of the scalp treatment, Olux Foam, began shipping last month, with exclusive marketing rights for 180 days. ... MLive.com TA-25 Index rises the most in 5 years - Mar 24, 2008 ...s Olux foam scalp treatment after a US judge refused to block shipments. Tambour rose the most since August, increasing 4.5%. The Israeli paint manufacturer ... Jerusalem Post פריגו עוקפת ×?ת התחזיות ×¢×? 435 מיליון דולר ×”×›× ×¡×•×ª - Feb 5, 2008 ...השקה × ×•×¡×¤×ª שצפויה עד סוף חודש מרץ ×”×™×? של תרופת ×”-Olux שמכירותיו ×”×©× ×ª×™×•×ª מסתכמות ב- 85 ... ynet ידיעות ×?×—×¨×•× ×•×ª - ynet ידיעות ×?×—×¨×•× ×•×ª Article: Skin-care products makers to merge: STIEFEL TO BUY PA'S … - Oct 24, 2006 OLUX(TM), and Ridaura(R), Connetics' FDA-approved products. Palo Alto-based Connetics is focused on the development of recombinant ... ... Pay-Per-View - San Jose Mercury News - HighBeam Research TOP TALENT AND RAPID R&D PUT CONNETICS ON FAST TRACK - - Apr 11, 2005 Connetics has four drugs on the market: Luxiq for scalp ailments, Evoclin for acne, OLUX for moderate psoriasis and Soriatane for severe psoriasis. ... $2.95 - San Jose Mercury News - NewsBank ת"×?: דשדוש הקיץ ת×?, תרדמת ×”×—×’×™×? כבר בפתח - Sep 3, 2006 ...מרשויות ×”-fda לייצור גרסה ×’× ×¨×™×ª של משחה המיועדת לטיפול בפסורי×?זיס בקרקפת - olux. ... NRG מעריב פריגו קיבלה ×?ישור ×ž×•×ª× ×” לשיווק תרופה בעלת היקף מכירות ×©× ×ª×™ של - Oct 3, 2006 ...בתחילת ספטמבר קיבלה פריגו מה-FDA ×?ישור ×ž×•×ª× ×” לשווק גירסה ×’× ×¨×™×ª לקצף Olux שפיתחה חברת ... ×”×?רץ Stiefel Plans $640M Acquisition Of Dermatology Firm Connetics - Oct 24, 2006 The company turned its attention to such products as Olux (clobetasol propionate) and Luxiq (betamethasone valerate) foams, marketed for scalp dermatoses. ... BioWorld Online - BioWorld Online Freestyle skiers aim for podium - Feb 23, 2006 Kyle Nissen of Calgary and Warren Shouldice of Quebec City hope to be on the podium when the aerial finals are held under the lights at Sauze d'Olux. ... TSN.ca Connetics Announces Expiration of Hart-Scott-Rodino Waiting Period. - Dec 15, 2006 The Company's marketed products are OLUX([R]) (clobetasol propionate) Foam, 0.05%; Lux[?]q([R]) (betamethasone valerate) Foam, 0.12%; Soriatane([R]) ... Free with registration - Business Wire - AccessMyLibrary.com Connetics Receives Notice from Nasdaq Due to Late Filing of Form 10... - May 19, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) ... Free with registration - Business Wire - AccessMyLibrary.com Connetics Licenses Technology for the Treatment of Hyperhidrosis. - Mar 7, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... Free with registration - Business Wire - AccessMyLibrary.com UREX Energy Corp. Upgraded to $3.00 per Share. - Nov 9, 2006 It offers OLUX Foam for the treatment of scalp dermatoses, and scalp and non-scalp psoriasis; Soriatane, an oral retinoid, to treat severe psoriasis in ... Free with registration - M2 Presswire - AccessMyLibrary.com Connetics Names Shari Geffon Senior Director, Project Management; … - Jun 5, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... Free with registration - Business Wire - AccessMyLibrary.com Connetics Names Tim Pergram Regional Sales Director; Reports New … - May 30, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... Free with registration - Business Wire - AccessMyLibrary.com Connetics Reports Positive Results From Second Phase III Clinical... - Aug 28, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) ... Free with registration - Business Wire - AccessMyLibrary.com Event Brief of Connetics Corporation Announces 2006 Financial … - Dec 19, 2005 CNCT filed a patent infringement lawsuit against Perrigo's Asia subsidiary and intends to vigorously defend its OLUX patent. 1. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Connetics Names Doris Boesch Director, Stability Programs; Reports … - Mar 24, 2006 The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) ... Free with registration - Business Wire - AccessMyLibrary.com |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |